{"doc_id": "si-2022-0042-reg-1", "parent_doc_id": "si-2022-0042", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": "1. These Regulations may be cited as the Health Act 1947 (Section 31A -", "text_raw": "1. These Regulations may be cited as the Health Act 1947 (Section 31A - \nTemporary Restrictions) (Covid-19) (Restrictions upon Travel to the State from \nCertain States) (No. 5) (Amendment) (No. 2) Regulations 2022.", "text_norm": "1 regulation may cited health act 1947 (section 31a - temporary restrictions) (covid-19) (restrictions upon travel state certain states) (no 5) (amendment) (no 2) regulation 2022", "start_char": 1320, "end_char": 1537, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
{"doc_id": "si-2022-0042-reg-2", "parent_doc_id": "si-2022-0042", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": "In these Regulations, “Principal Regulations” means the Health Act 1947", "text_raw": "2. \n\nIn these Regulations, “Principal Regulations” means the Health Act 1947 \n(Section 31A - Temporary Restrictions) (Covid-19) (Restrictions upon Travel to \nthe State from Certain States) (No. 5) Regulations 2021 (S.I. No. 135 of 2021).", "text_norm": "2 regulation principal regulation mean health act 1947 (section 31a - temporary restrictions) (covid-19) (restrictions upon travel state certain states) (no 5) regulation 2021 (s.i no 135 2021)", "start_char": 1537, "end_char": 1777, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
{"doc_id": "si-2022-0042-reg-3", "parent_doc_id": "si-2022-0042", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": "3. These Regulations shall come into operation on the 1st day of February", "text_raw": "3. These Regulations shall come into operation on the 1st day of February", "text_norm": "3 regulation shall come operation 1st day february", "start_char": 1777, "end_char": 1853, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
{"doc_id": "si-2022-0042-reg-2022", "parent_doc_id": "si-2022-0042", "section_id": "reg-2022", "section_label": "Regulation 2022.", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": null, "text_raw": "2022.", "text_norm": "2022", "start_char": 1853, "end_char": 1861, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
{"doc_id": "si-2022-0042-reg-4", "parent_doc_id": "si-2022-0042", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": "4. Regulation 1(3) of the Principal Regulations is amended by the", "text_raw": "4. Regulation 1(3) of the Principal Regulations is amended by the \n\nsubstitution of “31st day of March 2022” for “9th day of February 2022”.", "text_norm": "4 regulation 1(3) principal regulation amended substitution 31st day march 2022 9th day february 2022", "start_char": 1861, "end_char": 2004, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
{"doc_id": "si-2022-0042-reg-5", "parent_doc_id": "si-2022-0042", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": "5. Regulation 2 of the Principal Regulations is amended by the substitution", "text_raw": "5. Regulation 2 of the Principal Regulations is amended by the substitution \n\nof the following definition for the definition of “vaccinated person”: \n\n“ ‘vaccinated person’ means – \n\n(a) \n\na person, other than a person referred to in paragraph (b), to \nwhom – \n\n(i) \n\nthe medicinal product for active immunisation to prevent \nCovid-19 known as “Spikevax (previously COVID-19 \nVaccine Moderna) CX024414” has been administered such \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 4th February, 2022. \n\n \n \n \n \n \n \n \n \n \n\f[42] 3 \n\n(ii) \n\n(iii) \n\nthat the second dose of the medicinal product concerned has \nbeen administered to the person not less than 14 days and \nnot more than 270 days before his or her arrival in the State, \n\nthe medicinal product for active immunisation to prevent \nCovid-19 known as “Vaxzevria (previously COVID-19 \nVaccine AstraZeneca) ChAdOx1-SARS-COV-2”, also \nknown as “Covishield”, has been administered such that the \nsecond dose of the medicinal product concerned has been \nadministered to the person not less than 14 days and not \nmore than 270 days before his or her arrival in the State, \n\nthe medicinal product authorised for active immunisation to \nprevent Covid-19 known as “Comirnaty BNT162b2” has \nbeen administered such that the second dose of the \nmedicinal product concerned has been administered to the \nperson not less than 14 days and not more than 270 days \nbefore his or her arrival in the State, \n\n(iv) one dose of the medicinal product authorised for active \nimmunisation to prevent Covid-19 known as “COVID-19 \nVaccine Janssen (Ad26.COV2-S [recombinant])” has been \nadministered not less than 14 days and not more than 270 \ndays before his or her arrival in the State, \n\n(v) \n\n(vi) \n\nthe medicinal product for active immunisation to prevent \nCovid-19 known as “COVID-19 Vaccine (Vero Cell) \nInactivated”, also known as “CoronaVac”, has been \nadministered such that the second dose of the medicinal \nproduct concerned has been administered to the person not \nless than 14 days and not more than 270 days before his or \nher arrival in the State, \n\nthe medicinal product for active immunisation to prevent \nCovid-19 known as “Inactivated COVID-19 (VERO \nCELL) vaccine”, also known as “SinoPharm / BIBP”, has \nbeen administered such that the second dose of the \nmedicinal product concerned has been administered to the \nperson not less than 14 days and not more than 270 days \nbefore his or her arrival in the State, \n\n(vii) the medicinal product for active immunisation to prevent \nCovid-19 known as “Bharat Biotech BBV152”, also known \nas “COVAXIN”, has been administered such that the \nsecond dose of the medicinal product concerned has been \nadministered to the person not less than 14 days and not \nmore than 270 days before his or her arrival in the State, \n\n(viii) the medicinal product for active immunisation to prevent \nCovid-19 known as “Nuvaxovid (NVX-CoV2373)”, also \nknown as “Novavax”, has been administered such that the \nsecond dose of the medicinal product concerned has been \nadministered to the person not less than 14 days and not \nmore than 270 days before his or her arrival in the State, \n\n \n\f4 [42] \n\n(ix) any combination of the medicinal products referred to in \nsubparagraphs (i), (ii), (iii), (v), (vi), (vii) and (viii) has been \nadministered such that the second dose of the relevant \ncombination has been administered to the person not less \nthan 14 days and not more than 270 days before his or her \narrival in the State, or \n\n(x) one dose of a medicinal product referred to in subparagraph \n(i), (ii), (iii), (v), (vi), (vii) or (viii) has been administered \nnot more than 180 days after the person was subject to a \nRT-PCR test the result of which confirmed that Covid-19, \nor the virus SARS-CoV-2, was detected in the person at the \ntime of taking the test and which product has been \nadministered not less than 14 days and not more than 270 \ndays before his or her arrival in the State, or \n\n(b) \n\na person to whom – \n\n(i) \n\n(ii) \n\nthe relevant dose or doses, as the case may be, specified in \nany of subparagraphs (i) to (x) of paragraph (a) has or have \nbeen administered, whether within 270 days before his or \nher arrival in the State or otherwise, and \n\nan additional dose or a booster or subsequent dose of a \nmedicinal product referred to in subparagraphs (i) to (viii) \nof paragraph (a) has been administered before his or her \narrival in the State.”. \n\nGIVEN under the Official Seal of the Minister for Health, \n\n31 January, 2022. \n\nMUIRIS O'CONNOR, \n\nA person authorised under section 15 \nof the Ministers and Secretaries Act \n1924 to authenticate the seal of the \nMinister for Health. \n\n \n \n \n \n \n \n \n\f[42] 5", "text_norm": "5 regulation 2 principal regulation amended substitution following definition definition vaccinated person vaccinated person mean - (a) person person referred paragraph (b) - (i) medicinal product active immunisation prevent covid-19 known spikevax (previously covid-19 vaccine moderna) cx024414 administered notice making statutory instrument published iris oifigiuil 4th february 2022 42 3 (ii) (iii) second dose medicinal product concerned administered person le 14 day 270 day arrival state medicinal product active immunisation prevent covid-19 known vaxzevria (previously covid-19 vaccine astrazeneca) chadox1-sars-cov-2 also known covishield administered second dose medicinal product concerned administered person le 14 day 270 day arrival state medicinal product authorised active immunisation prevent covid-19 known comirnaty bnt162b2 administered second dose medicinal product concerned administered person le 14 day 270 day arrival state (iv) one dose medicinal product authorised active immunisation prevent covid-19 known covid-19 vaccine janssen (ad26.cov2-s recombinant ) administered le 14 day 270 day arrival state (v) (vi) medicinal product active immunisation prevent covid-19 known covid-19 vaccine (vero cell) inactivated also known coronavac administered second dose medicinal product concerned administered person le 14 day 270 day arrival state medicinal product active immunisation prevent covid-19 known inactivated covid-19 (vero cell) vaccine also known sinopharm bibp administered second dose medicinal product concerned administered person le 14 day 270 day arrival state (vii) medicinal product active immunisation prevent covid-19 known bharat biotech bbv152 also known covaxin administered second dose medicinal product concerned administered person le 14 day 270 day arrival state (viii) medicinal product active immunisation prevent covid-19 known nuvaxovid (nvx-cov2373) also known novavax administered second dose medicinal product concerned administered person le 14 day 270 day arrival state 4 42 (ix) combination medicinal product referred subparagraphs (i) (ii) (iii) (v) (vi) (vii) (viii) administered second dose relevant combination administered person le 14 day 270 day arrival state (x) one dose medicinal product referred subparagraph (i) (ii) (iii) (v) (vi) (vii) (viii) administered 180 day person subject rt-pcr test result confirmed covid-19 virus sars-cov-2 detected person time taking test product administered le 14 day 270 day arrival state (b) person - (i) (ii) relevant dose dos case may specified subparagraphs (i) (x) paragraph (a) administered whether within 270 day arrival state otherwise additional dose booster subsequent dose medicinal product referred subparagraphs (i) (viii) paragraph (a) administered arrival state  given official seal minister health 31 january 2022 muiris connor person authorised section 15 minister secretary act 1924 authenticate seal minister health 42 5", "start_char": 2004, "end_char": 6747, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
{"doc_id": "si-2022-0042-explanatory-note", "parent_doc_id": "si-2022-0042", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 42 of 2022", "title": "other Emergency Measures in the Public Interest) Act 2020 (No. 1 of 2020)) of", "year": 2022, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Health Act 1947 (Section 31A - Temporary \nRestrictions) (Covid-19) (Restrictions upon Travel to the State from States) (No. \n5) Regulations 2021 (S.I. No. 135 of 2021) to provide for the acceptance of an \nadditional vaccine product for travel purposes, to limit the standard acceptance \nperiod of proofs of vaccination in respect of primary vaccine courses to 270 days \nand to provide for acceptance of vaccination certificates issued for booster doses. \n\n \n \n \n \n \n \n \n\f6 [42] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€3.00 \n\n(DH-376) 75. 2/22. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend health act 1947 (section 31a - temporary restrictions) (covid-19) (restrictions upon travel state states) (no 5) regulation 2021 (s.i no 135 2021) provide acceptance additional vaccine product travel purpose limit standard acceptance period proof vaccination respect primary vaccine course 270 day provide acceptance vaccination certificate issued booster dos 6 42 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur3.00 (dh-376) 75 2 22 propylon", "start_char": 6747, "end_char": 7852, "source_path": "downloads\\2022\\2022_0041.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80927d1c57415eb5af614d5cfe5b39f77f917c35c846c075f2b6ca1f4d3dbc5e", "cross_refs": []}
